Bogart Wealth’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$670 – 2136
2026
Q2
$670 Buy
2
+1
+100% +$317 ﹤0.01% 1707
2026
Q1
$322 Buy
+1
New +$309 ﹤0.01% 1665

Other funds holding PRAX

Bogart Wealth's PRAX Position: Q3 2026 in Review

Bogart Wealth sold out of Praxis Precision Medicines (PRAX) in Q3 2026, closing a stake of 2 shares — an estimated $670 sold.

Bogart Wealth first reported a position in PRAX in Q1 2026 and held it in 2 quarters. The position peaked at $670 in Q2 2026. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Bogart Wealth reported no remaining Praxis Precision Medicines position as of Q3 2026 after selling out during the quarter.
  • Bogart Wealth sold 2 Praxis Precision Medicines shares in Q3 2026, an estimated $670.
  • Bogart Wealth first reported a position in Praxis Precision Medicines in Q1 2026 and held it in 2 quarters.
  • Bogart Wealth's Praxis Precision Medicines position peaked at $670 in Q2 2026.
  • 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.